HR. 2821Reported
FDA Modernization Act 3.0
Impact Score
52
Limited
Momentum
54
Active
Summary
Modernize Food and Drug Administration testing and approval processes for drugs and biologics under the FDA Modernization Act 3.0
What this does
- Modify FDA testing processes
Latest action
2026-05-21 — Ordered to be Reported by the Yeas and Nays: 44 - 0.